Chugai Pharmaceutical stock has October 27 results scheduled pre-market
Published on 10/19/2026 at 08:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults date approaches
- Chugai Pharmaceutical has scheduled its fiscal 2026 third-quarter results for October 27, 2026.
- The company researches, develops, manufactures and sells medicines in Japan and international markets.
- Chugai Pharmaceutical stock trades pre-market at EUR 35.50 at 8:16 a.m. CEST at Lang & Schwarz on October 19, 2026.
Chugai Pharmaceutical’s investor-relations calendar lists fiscal 2026 third-quarter results for October 27, 2026. Chugai Pharmaceutical stock trades pre-market at EUR 35.50 at 8:16 a.m. CEST at Lang & Schwarz on October 19, 2026.
Third-quarter results scheduled
The company’s calendar also lists a conference on the fiscal 2026 third-quarter financial results for October 27, 2026, at 6:00 p.m. Japan Standard Time. The scheduled events are listed by Chugai Pharmaceutical.
Ahead of the Xetra open
The pre-market indication is EUR 35.50 at Lang & Schwarz. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Chugai Pharmaceutical stock.
The group and its market
Chugai researches, develops, manufactures and sells pharmaceutical products in Japan and international markets. Its next scheduled company event is the fiscal 2026 third-quarter results release on October 27, 2026, followed by a results conference at 6:00 p.m. Japan Standard Time. Market context: Market report Nikkei 225.
